Match tier Likely match
Presence Current · Arkansas
Last published 2026
Sources OpenAlex · ORCID
Refreshed 2026-08-08

Adeniyi Oyebade

This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.

Graduate Student

Graduate Student Researcher

4 h-index 9 pubs 52 cited

  • Nanomedicine
  • Doxorubicin
  • Endocytosis
  • Humans
  • MCF-7 Cells
  • Antineoplastic Agents
  • Macrocyclic Compounds
  • Histone Deacetylase Inhibitors
  • Antibiotics, Antineoplastic
  • Biocompatible Materials
  • Cell Survival
  • Drug Screening Assays, Antitumor
  • Ions
  • Materials Testing
  • Particle Size

Biography and Research Information

OverviewAI-generated summary

Adeniyi Oyebade's research focuses on the development and application of nanomedicines for therapeutic purposes. His work includes investigating doxorubicin-based ionic nanomedicines for combined chemo-phototherapy of cancer, exploring the role of endocytosis pathways in drug delivery, and studying the enhanced killing of bacteria using antibiotics coupled with photothermal therapy. Oyebade has also examined the potential of targeted drug delivery systems, such as using epidermal growth factor receptors for rapamycin delivery in pancreatic cancer cells.

His publications also extend to materials science, including research on carbon-based anode materials for metal-ion batteries and the physicochemical properties of oils from underutilized citrus seeds. Oyebade collaborates with several researchers at the University of Arkansas at Little Rock, including Noureen Siraj, Mujeebat Bashiru, Nawab Ali, and Mavis Forson, with whom he shares multiple publications.

Metrics

  • h-index: 4
  • Publications: 9
  • Citations: 52

Selected Publications

  • Macrocyclic histone deacetylase inhibitor-based near-infrared-responsive ionic nanomedicines for enhanced cancer therapy (2026)
    International Journal of Pharmaceutics DOI OpenAlex
  • Carbon-Based Anode Materials for Metal-Ion Batteries: Current Status, Challenges, and Future Directions (2025)
    Batteries 7 citations DOI OpenAlex
  • Targeted Delivery of Rapamycin via Epidermal Growth Factor Receptors in Pancreatic Cancer Cells Inhibits Cell Proliferation and Induces Apoptosis (2025)
    ACS Omega 1 citation DOI OpenAlex
  • Comparative Study of the Physicochemical Properties of Oil from Underutilized Seeds of Citrus Paradisi, Citrus Lemon and Citrus Sinensis (2025)
    European Journal of Theoretical and Applied Sciences DOI OpenAlex
  • IONIC NANOMEDICINE STRATEGY TO DEVELOP EFFECTIVE CHEMO-PTT COMBINATION CANCER THERAPEUTICS (2024)
    PubMed DOI OpenAlex
  • Interrogating the Role of Endocytosis Pathway and Organelle Trafficking for Doxorubicin-Based Combination Ionic Nanomedicines (2024)
    ACS Applied Bio Materials 6 citations DOI OpenAlex
  • Microplastics: Challenges, toxicity, spectroscopic and real-time detection methods (2024)
    Applied Spectroscopy Reviews 27 citations DOI OpenAlex
  • Doxorubicin-Based Ionic Nanomedicines for Combined Chemo-Phototherapy of Cancer (2024)
    ACS Applied Nano Materials 9 citations DOI OpenAlex
  • Antibiotics Coupled with Photothermal Therapy for the Enhanced Killing of Bacteria (2023)
    Journal Of Biochemical Technology 2 citations DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

42 Collaborators 15 Institutions 2 Countries

Top Collaborators

View profile →
View profile →
View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics